secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001193125-26-140053
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla to effect 1-for-50 reverse stock split via merger effective April 6, 2026
--------------------------------------------------------------------------------

- Certificate of Merger filed April 2, 2026; merger effective April 6, 2026 at 12:01 a.m. Eastern Time.
- Every 50 outstanding shares of common stock will be converted into 1 share.
- Merger with wholly owned subsidiary BA Merger Sub, Inc.; BioAtla is the surviving corporation.
- No change to company name or business; charter remains as in effect prior to merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526140053/0001193125-26-140053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526140053/bcab-20260402.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-140053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer